Results of single-center screening for chronic hepatitis E in children after liver transplantation and report on successful treatment with ribavirin

Pediatr Transplant. 2013 Jun;17(4):343-7. doi: 10.1111/petr.12077. Epub 2013 Apr 3.

Abstract

RNA screening for HEV in 22 liver-transplanted children with chronic graft hepatitis out of a cohort of 267 liver-transplanted children detected a single patient with chronic HEV infection. Although this patient remained viremic for 33 months, anti-HEV-IgG was not detectable with MP assay but with Wantai assay. We present the first case of successful ribavirin therapy in an immunosuppressed child with chronic HEV infection. In conclusion, chronic HEV infection in immunosuppressed children may not be detectable employing serological assays. Therefore, the most reliably screening method is screening for HEV-RNA. Chronic HEV infection in children can successfully be treated with ribavirin.

MeSH terms

  • Adolescent
  • Antibodies, Viral / blood
  • Antiviral Agents / therapeutic use
  • Child
  • Child, Preschool
  • Cohort Studies
  • Female
  • Hepatitis / etiology
  • Hepatitis / virology*
  • Hepatitis E / diagnosis*
  • Hepatitis E / drug therapy*
  • Hepatitis E / virology
  • Humans
  • Immunoglobulin G / blood
  • Immunosuppressive Agents / adverse effects
  • Infant
  • Liver Failure / complications
  • Liver Failure / therapy*
  • Liver Transplantation / adverse effects*
  • Male
  • Polymerase Chain Reaction
  • Postoperative Complications
  • RNA, Viral / analysis
  • Retrospective Studies
  • Ribavirin / therapeutic use*

Substances

  • Antibodies, Viral
  • Antiviral Agents
  • Immunoglobulin G
  • Immunosuppressive Agents
  • RNA, Viral
  • Ribavirin